What A Strategic Advisor Actually Buys You Across Three Markets

Hiring a Strategic Advisor at a start-up is a big decision. Founders and Boards have to consider what such an advisor would bring to the relationship, and the benefits differ based on whether you are in the UK, US, or EU. The question behind the question is sharp: “Why would I pay for judgment when what I seem to be missing is hands?”

The Easy Answer

In the modern year of 2026, the constraint on the business is rarely headcount…it is judgment about where AI, regulation, and commercialisation intersect, and how those choices translate into an investor-grade story. Capital (whether Venture or Private Equity) has stopped rewarding experimentation. Global insurtech funding rebounded to $2.8bn across 96 deals in H1 2026, up 86% year on year, even as deal count fell 7%. As we’ve discussed in earlier editions, this tells us that money is concentrating into fewer, larger, but more viable bets. A strategic advisor earns their place when they help a firm become one of those big bets, not one of many that quietly runs out of runway.

How The Market Changed

A former colleague of mine used to say, “Context is worth 40 IQ points.” The context of the market here matters quite a lot, because it changes what “good advice” looks like and how it can impact fundraising and business results. The US is now the deepest pool for scale-up capital in the world, taking a 62% share of global insurtech activity in Q2 2026 and eight of the ten largest deals for the quarter. The UK holds a steady second place at around 9%, but the domestic funding pool has tightened to roughly £300m to £400m ($375m - $500m) across stages (far below the 2020 to 2021 peak). UK fintech funding fell to a decade low of £1.8bn ($2.25bn) in H1 2026, down about 66% year on year.

This tightening is all based on one clear signal…of the $2.44bn raised in Q2 2026, some 99.1% went to AI-focused companies. In UK fintech, AI-related investment still reached £445m ($555m) across 79 deals (a quarter of the total). Meanwhile, European investors have grown highly selective, pulling back from lending, banking infrastructure, and insurtech while leaning into regtech, digital assets, and payments.

The environment is clearly rewarding three things: a credible AI thesis, obvious commercial leverage, and fluency across regulatory regimes that often do not agree.

Few founding teams carry all three internally…but the reward for a trifecta are tremendous (just ask the team at Corgi).

What Do Boards And Founders Want

Having spent years running strategy at large companies and sitting on both sides of the due diligence table, I would put the real demand into a short list of clear deliverables:

A clear AI strategy with measurable return. Capital is skewed so heavily to AI-enabled businesses that a vague roadmap now reads as a red flag. Boards want to see how an AI-driven model touches the business (loss ratio, claims cycle time, underwriting accuracy, fraud, etc.), and they want defensible numbers. If your AI story cannot be traced to a line on the P&L, investors will ask what exactly you are having them fund.

Commercial execution over pure innovation. KPMG counts only 124 insurtech deals globally in H1 2026, which could make 2026 the weakest year for count since 2016. That means that deal volumes are coming under severe pressure, investors reward operational execution and business model leverage over novelty. The clever demo no longer wins. Can you show a repeatable process that turns product into distribution, and is smarter, faster, and more viable than the incumbents or other start-ups? This is the question you will be asked to answer and demonstrate in later rounds.

Cross-border regulatory fluency. Data, distribution, and model-risk standards differ across the UK, US, and EU. A strategy that works in one regime can quietly become a liability in another. This is where a poison pill surfaces mid-integration: a distribution assumption baked into the US model that no EU regulator will allow. Who on your team has actually operated inside all three jurisdictions and what is their input on the differentials between them?

Capital efficiency and a real path toward profitability. Selective funding means the burn conversation happens earlier and are chillier than prior cycles. Boards want to see disciplined unit economics, not a hockey stick that assumes the good times will never end. How many months of judgment, not just cash, do you have left?

Where Are Advisors Creating Wedges

Think of the engagement this way…the retainer and the title are the skin; the two or three decisions the advisor genuinely owns are the bones. If a VC or Founder cannot name those decisions, you have bought decoration, not a real asset. In practice the wedge is strongest in three use cases across carriers, MGAs, brokers, Insurtechs, Fintechs, and other regulated entities.

Fundraising And Investor Positioning

I see lots of gaps between what a technical team has built and how a growth-stage investor scores it. An advisor’s job here is to convert capability (technical, product, GTM, etc.) into an investor-grade story: how the technology moves the business; how product gets shipped; how go-to-market is effective, and the connective tissue between the three. Given that the largest cheques now sit in the US, part of the work is deciding where you raise vs where your operating base lives.

Market Expansion Across Jurisdictions

Accessing insurers, brokers, MGAs, and finance channels across differentiated markets is not the same process repeated three times. These distinct motions that share a brand and a board. An advisor who has run market entry across multiple jurisdictions can sequence which geographies goes first, which partnerships to prioritise, and which regulatory constraints must shape the product before a launch.

Operating-Model Transformation

For incumbents and scale-ups alike, the hardest work is turning an AI ambition into a redesigned decisioning workflow that a board can measure. This is where a fractional executive with operational experience adds more than a report ever will.

A Question Worth Putting To Your Board

Before you decide between an advisor, a hire, or nothing, sit the board down and ask a short set of questions openly and honestly:

“Can we trace our AI roadmap to a specific, defensible number on the top or bottom line of the business?”

“Do we have anyone on staff who has operated across UK, US, and EU regulatory regimes, or are we assuming they translate?”

“Are we raising where the capital is deepest, or where our habits tell us?”

If the answers are shaky, you have a judgment problem, and that is precisely what an advisor is meant to uncover and help you manage through.

The Point

A strategic advisor will never deliver an ROI as a passive retainer collecting a fee while the plan drifts. The value shows up when the advisor owns a small number of consequential decisions, gives you one hand to shake, and stakes their credibility on the outcome. In a market this concentrated and this selective, that is not a luxury line item…it is the difference between being one of the 96 funded and one of the many that never gets a meeting.

Key Takeaways

Capital is concentrating, not disappearing. H1 2026 insurtech funding rose 86% year on year even as deal count fell, so the game is being one of fewer, larger bets rather than one of many small ones. Position accordingly.

AI without a measurable number is now a red flag. With 99.1% of Q2 2026 insurtech capital going to AI-focused firms, boards expect roadmaps traced to loss ratio, claims efficiency, fraud, or combined-ratio impact. Vagueness reads as weakness.

Cross-border fluency is a scarce, high-value skill. UK, US, and EU regimes diverge on data, distribution, and model risk, and assumptions that travel unchecked become liabilities mid-integration.

The advisory wedge is three use cases. Fundraising and investor positioning, market expansion across jurisdictions, and operating-model transformation are where an advisor with operator credibility earns their place.

Buy bones, not skin. If you cannot name the two or three decisions an advisor genuinely owns, you have bought decoration rather than judgment.